SUNZEN BIOTECH BHD

KLSE (MYR): SUNZEN (0148)

You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!

Last Price

0.315

Today's Change

0.00 (0.00%)

Day's Change

0.00 - 0.00

Trading Volume

0

Financial

Show?
Last 10 FY Result
AQR T4Q 30/06/24 30/06/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 142,699 99,889 142,699 0 97,103 90,444 82,233 239,864 300,429 303,451 40,013 32,221 19.12%
PBT 15,686 11,942 15,686 0 7,348 3,730 -12,704 -20,557 -6,941 4,012 -455 -259 -
Tax -5,251 -3,789 -5,251 0 -2,695 -1,765 -209 1,401 4 -372 395 -88 61.73%
NP 10,435 8,153 10,435 0 4,653 1,965 -12,913 -19,156 -6,937 3,640 -60 -347 -
-
NP to SH 9,172 7,177 9,172 0 3,636 698 -13,231 -17,460 -6,870 3,474 -130 -348 -
-
Tax Rate 33.48% 31.73% 33.48% - 36.68% 47.32% - - - 9.27% - - -
Total Cost 132,264 91,736 132,264 0 92,450 88,479 95,146 259,020 307,366 299,811 40,073 32,568 17.91%
-
Net Worth 141,158 141,158 141,158 120,335 120,335 96,958 89,890 89,758 101,148 100,837 89,722 52,200 12.40%
Dividend
AQR T4Q 30/06/24 30/06/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Div - - - - - - - - - 1,440 - - -
Div Payout % - - - - - - - - - 41.47% - - -
Equity
AQR T4Q 30/06/24 30/06/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Net Worth 141,158 141,158 141,158 120,335 120,335 96,958 89,890 89,758 101,148 100,837 89,722 52,200 12.40%
NOSH 728,480 728,480 728,480 707,854 720,540 625,462 535,046 535,046 525,195 482,318 479,124 290,000 11.43%
Ratio Analysis
AQR T4Q 30/06/24 30/06/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin 7.31% 8.16% 7.31% 0.00% 4.79% 2.17% -15.70% -7.99% -2.31% 1.20% -0.15% -1.08% -
ROE 6.50% 5.08% 6.50% 0.00% 3.02% 0.72% -14.72% -19.45% -6.79% 3.45% -0.14% -0.67% -
Per Share
AQR T4Q 30/06/24 30/06/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
RPS 20.22 14.15 20.22 0.00 13.72 15.86 15.55 45.43 59.40 63.20 8.92 11.11 7.29%
EPS 1.30 1.02 1.30 0.00 0.51 0.12 -2.50 -3.31 -1.36 0.72 -0.03 -0.12 -
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.30 0.00 0.00 -
NAPS 0.20 0.20 0.20 0.17 0.17 0.17 0.17 0.17 0.20 0.21 0.20 0.18 1.24%
Adjusted Per Share Value based on latest NOSH - 728,480
AQR T4Q 30/06/24 30/06/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
RPS 17.74 12.42 17.74 0.00 12.07 11.24 10.22 29.82 37.35 37.72 4.97 4.01 19.10%
EPS 1.14 0.89 1.14 0.00 0.45 0.09 -1.64 -2.17 -0.85 0.43 -0.02 -0.04 -
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.18 0.00 0.00 -
NAPS 0.1755 0.1755 0.1755 0.1496 0.1496 0.1205 0.1118 0.1116 0.1257 0.1254 0.1115 0.0649 12.40%
Price Multiplier on Financial Quarter End Date
AQR T4Q 30/06/24 30/06/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Date 28/06/24 28/06/24 28/06/24 30/06/23 30/12/22 31/12/21 31/12/20 31/12/19 31/12/18 29/12/17 30/12/16 31/12/15 -
Price 0.35 0.35 0.35 0.21 0.20 0.25 0.18 0.105 0.165 0.31 0.205 0.42 -
P/RPS 1.73 2.47 1.73 0.00 1.46 1.58 1.16 0.23 0.28 0.49 2.30 3.78 -8.78%
P/EPS 26.93 34.42 26.93 0.00 38.94 204.28 -7.19 -3.18 -12.15 42.85 -707.43 -350.00 -
EY 3.71 2.91 3.71 0.00 2.57 0.49 -13.90 -31.49 -8.23 2.33 -0.14 -0.29 -
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.97 0.00 0.00 -
P/NAPS 1.75 1.75 1.75 1.24 1.18 1.47 1.06 0.62 0.83 1.48 1.03 2.33 -3.31%
Price Multiplier on Announcement Date
AQR T4Q 30/06/24 30/06/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Date 29/08/24 29/08/24 29/08/24 - 23/02/23 25/02/22 25/02/21 27/02/20 28/02/19 27/02/18 28/02/17 25/02/16 -
Price 0.315 0.315 0.315 0.00 0.205 0.265 0.19 0.10 0.175 0.275 0.29 0.33 -
P/RPS 1.56 2.23 1.56 0.00 1.49 1.67 1.22 0.22 0.29 0.44 3.25 2.97 -7.29%
P/EPS 24.24 30.98 24.24 0.00 39.91 216.54 -7.59 -3.02 -12.88 38.01 -1,000.76 -275.00 -
EY 4.13 3.23 4.13 0.00 2.51 0.46 -13.17 -33.07 -7.76 2.63 -0.10 -0.36 -
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.09 0.00 0.00 -
P/NAPS 1.57 1.57 1.57 0.00 1.21 1.56 1.12 0.59 0.88 1.31 1.45 1.83 -1.78%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
5 people like this. Showing 50 of 2,218 comments

Wixson

Great, SUNZEN still managed to stay above 30 cents today 👏

2024-08-05 19:43

RamsyNa

Looks like today is a great opportunity to accumulate

2024-08-05 20:43

GGstarz

This week SUNZEN can move back to 0.34

2024-08-06 15:40

nbatofu

caught some at 0.31... cheap & nice to hold... if this week can climb back like you say then nice lor..

2024-08-06 16:01

VeneerWood

Only 2 more cents for Sunzen to hit 34 cents. Easy-peasy

2024-08-06 16:50

Wixson

Breaks out when the company announces next QR this month end 😉

2024-08-06 19:55

emptech

Sunzen going up little bit day by day, no more cheap tickets left

2024-08-07 15:28

ameeya13

next qr should see some improvement with the positive growth of biotech industry

2024-08-07 16:20

RamsyNa

TP 0.40 when SUNZEN announces quarterly results

2024-08-07 16:49

VeneerWood

Then right now is an accumulation phase

2024-08-07 19:29

Wixson

I think dah habis cuci .. Sunzen might soars at any time 😊

2024-08-08 12:20

nbatofu

most retail wash out past few days... 31 is the cheapest now...

2024-08-08 14:14

gloveshapiro

0.31-0.32 is a steady & cheap entry price now, Sunzen entering the healthcare sector will push the price further up

2024-08-08 15:07

VeneerWood

Just keep accumulating if you have extra bullets

2024-08-08 15:56

GGstarz

hidden star of 2024 ni, test 0.34 resistance next week

2024-08-09 15:51

03zerothreee

Strong growth every quarter, Sunzen future prospect is really bright with new acquisition

2024-08-09 16:10

RamsyNa

Sunzen's returns on capital are heading higher. Buy & hold it for long run

2024-08-09 16:11

Wixson

Its ROCE is around 8.1% if using FY2023 figures

2024-08-09 19:23

emptech

slow week ahead before result is out end of this month

2024-08-12 15:54

VeneerWood

No worries, it's a sign of quiet before the storm 😬

2024-08-12 16:24

ameeya13

biotech industry having positive growth, good QR for Sunzen for sure!

2024-08-12 16:30

Wixson

Next quarter's revenue and net profit will both increase quarter-on-quarter and year-on-year, I believe

2024-08-12 20:08

nbatofu

0.31 is cheapest price now, sunzen stay strong

2024-08-13 15:55

RamsyNa

Sunzen has decreased current liabilities to 6.3% of total assets over this period. Good sign

2024-08-13 16:15

gloveshapiro

nice... entering into healthcare sector is a correct decision

2024-08-13 16:19

VeneerWood

Worth to invest it for long term 🤝

2024-08-13 17:36

Rose001

Post removed.Why?

1 month ago

GregBursa

I just watched it. Must say the new management seems to be doing the right thing compare to the previous one. At least now SUNZEN is no longer losing money but making profit

1 month ago

Greenbull88

Sunzen will be one of the best performing stock in year 2025

1 month ago

jaynetan

I joined

1 month ago

Greenbull88

Hopes the Xmegami lenglui will buy in sunzen also since their earning so high every month

1 month ago

Greenbull88

China market so bullish, hopes Sunzen main export to China will benefit

1 month ago

GregBursa

Watched the technical analysis here https://youtu.be/9V0_mkxG1sw?si=M-l0iuIJeU4w9q5Q

1 month ago

mf

Dow Jones

Dow Jones Industrial Average

42,011.59

-184.93

0.43%

Nasdaq

NASDAQ Composite

17,918.47

-6.64

0.03%

1 month ago

Greenbull88

Hearsay sunzen will hit RM1 in 2025

1 month ago

biggie0000

director dispose...

4 weeks ago

Wixson

Share price still steady after that, biggie0000. We wait for the next rally to come

2 weeks ago

Greenbull88

Good company and will be jackpot in 2025

2 weeks ago

RamsyNa

As consumers pay more and more attention to preventive health care and natural remedies, Sunzen's traditional Chinese medicine and human health supplement products have huge growth potential

2 weeks ago

gloveshapiro

Re-enter 0.315, Sunzen Q3 will back above 2m profit again

2 weeks ago

VeneerWood

Nice grab, gloveshapiro. If the QR is good as expected, it probably will break 35 cents

2 weeks ago

ameeya13

0.31-0.32 is a nice entry price, better buy while sunzen is consolidating

1 week ago

RamsyNa

SUNZEN-WC is nice too. Premium is 0 😁

1 week ago

emptech

Sunzen Biotech eyes bigger share of China bird’s nest market. Sunzen subsidiary Ecolite Biotech Manufacturing Sdn Bhd has received approval from China’s customs authority in October last year to export its bottled bird’s nest to the country up to 2028.

1 week ago

Wixson

The demand for edible bird’s nest products is indeed strong in China, Hong Kong, and other parts of Southeast Asia. The Chinese market, in particular, is one of the largest consumers of bird’s nests, driven by a cultural preference for traditional health products and rising disposable incomes

1 week ago

GGstarz

non-stop expansion & acquisition, Sunzen slow & steady je

1 week ago

ameeya13

biotech industry is slowing growing, end of nov qr should see some improvement

3 days ago

VeneerWood

Sunzen's loan financing business is expected to continue to grow given the increasing trend in the number of applications and approvals, mainly due to our ability to provide fast and efficient services and structure more flexible loan packages to meet the needs of the SME market.

3 days ago

nbatofu

Acquisition of Eye Nation Medical is expected to contribute positively to the future financial performance of the Sunzen group, enhancing the group’s revenue and profitability, as it is secured by a profit guarantee of an audited profit after tax of RM2.60 million over the next two financial years

1 day ago

RamsyNa

Then SUNZEN will be able to achieve over RM1 million of net profit in the next quarter 😀

8 hours ago

Post a Comment